Development of Novel Activin-Targeted Therapeutics-Reference-Cited by-同舟云学术

Development of Novel Activin-Targeted Therapeutics

Published:2015-03 Issue:3 Volume:23 Page:434-444
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Chen Justin L,Walton Kelly L,Al-Musawi Sara L,Kelly Emily K,Qian Hongwei,La Mylinh,Lu Louis,Lovrecz George,Ziemann Mark,Lazarus Ross,El-Osta Assam,Gregorevic Paul,Harrison Craig A

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference43 articles.

1. Generation of a specific activin antagonist by modification of the activin A propeptide;Makanji;Endocrinology,2011

2. Activin-A binds follistatin and type II receptors through overlapping binding sites: generation of mutants with isolated binding activities;Harrison;Endocrinology,2006

3. Smad transcription factors;Massagué;Genes Dev,2005

4. Administration of a soluble activin type IIB receptor promotes skeletal muscle growth independent of fiber type;Cadena;J Appl Physiol,2010

5. Inhibiting activin-A signaling stimulates bone formation and prevents cancer-induced bone destruction in vivo;Chantry;J Bone Miner Res,2010

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activin A-Targeted Therapy in Cancer: An Updated Review on Challenges and Opportunities in Clinical Translation;Current Pharmaceutical Design;2024-08-27

2. Targeting activins and inhibins to treat reproductive disorders and cancer cachexia;Journal of Endocrinology;2023-04-20

3. Myostatin: A Skeletal Muscle Chalone;Annual Review of Physiology;2023-02-10

4. Follistatin Forms a Stable Complex With Inhibin A That Does Not Interfere With Activin A Antagonism;Endocrinology;2023-01-09

5. Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin;Journal of Cachexia, Sarcopenia and Muscle;2022-05-05